Sudden Cardiac Death in Patients With Atrial Fibrillation: Insights From the ENGAGE AF-TIMI 48 Trial. [electronic resource]
Producer: 20180105ISSN:- 2047-9980
- Adrenergic beta-Antagonists -- therapeutic use
- Aged
- Atrial Fibrillation -- epidemiology
- Cardiotonic Agents -- therapeutic use
- Death, Sudden, Cardiac -- epidemiology
- Digitalis Glycosides -- therapeutic use
- Factor Xa Inhibitors -- therapeutic use
- Female
- Heart Failure -- epidemiology
- Heart Rate
- Humans
- Hypertrophy, Left Ventricular -- epidemiology
- Incidence
- Male
- Middle Aged
- Multivariate Analysis
- Myocardial Infarction -- epidemiology
- Out-of-Hospital Cardiac Arrest -- epidemiology
- Proportional Hazards Models
- Protective Factors
- Pyridines -- therapeutic use
- Risk Factors
- Stroke Volume
- Thiazoles -- therapeutic use
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.